Skip to content

Molecular plasticity of HFpEF (SFB1470 - B05)

Molecular plasticity of HFpEF (SFB1470 - B05) - SFB1470 - B05

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032999
Enrollment
60
Registered
2023-12-04
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart insufficiency

Interventions

Group 1: In this clinical study, the effectiveness of regular physical training on patients with heart failure with preserved left ventricular ejection fraction (HFpEF) is investigated by comparing a

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age = 18 years 2) Written informed consent 3) Presence of signs and symptoms of heart failure corresponding to a NYHA class = 2. 4) Echocardiographically preserved ejection fraction (LVEF = 50%). 5) NTproBNP >125 (SR) or >365 (VHFL) pg/mL or BNP >35 (SR) or >105 (VHL) pg/mL. 6) Existence of structural or functional cardiac changes compatible with LV diastolic dysfunction or elevated left ventricular filling pressures, respectively. Applicability of at least one of the following echocardiographic or invasive criteria: - LV mass index = 95 g/m2 (women), >_115 g/m2 (men) and relative wall thickness >0.42 - LA volume index > 34mL/m2 (SR) or > 40 ml/m2 (VHFL). - E/e' ratio at rest = 13 - PA systolic pressure >35 mmHg (invasive under stress). - TR velocity at rest > 2.8 m/s (invasive under stress)

Exclusion criteria

Exclusion criteria: 1) Life expectancy 2) or severe anemia (Hb<10g/dl in men and Hb <9.5g/dl in women).

Design outcomes

Primary

MeasureTime frame
Maximum exercise capacity (peakVO2, measured by spiroergometry) after 12 weeks of training or control intervention

Secondary

MeasureTime frame
- Change in ventilatory efficiency (VE/VCO2 slope) and submaximal performance (distance in 6-minute walk test, anaerobic threshold) - Change in muscle strength (e.g. measured by hand grip) - Change in body composition - Change in quality of life (e.g. KCCQ, SF-36) Change in cognition (e.g. PROMs, CANTAB) -Change in echocardiographic parameters of cardiac (left and right heart) morphology and function at rest and during exercise - Changes in markers of neuroendocrine activation (e.g. NT-proBNP), inflammation, collagen turnover and fibrosis as well as metabolic parameters - Frailty in the context of the cardiac support system and the interaction with training - Long-term effects of training - Change in daily physical activity - Adherence to training plans - Safety and tolerability of the training intervention Gender-relevant aspects of all primary and secondary endpoints

Countries

Germany

Contacts

Public ContactFrank Edelmann

Deutsches Herzzentrum der Charité Klinik für Kardiologie, Angiologie und Intensivmedizin Campus Virchow-Klinikum

frank.edelmann@charite.de+49 30 450 653 731

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026